期刊文献+

头孢替安钠与呋塞米合用对大鼠肾功能的影响 被引量:2

Effect of Cefotiam Sodium Combined with Furosemide on Renal Function in Rats
下载PDF
导出
摘要 目的:评价头孢替安钠与呋塞米合用的安全性,为临床用药提供参考。方法:设空白组、头孢替安钠500 mg·kg-1·d-1组、头孢替安钠500 mg·kg-1·d-1+呋塞米15 mg·kg-1·d-1组,给药12d后检测大鼠肾脏结构,以及血清尿酸、肌酐、尿素氮,大鼠尿α1微球蛋白,β2微球蛋白等水平。结果:头孢替安钠500 mg·kg-1·d-1给药后对大鼠的肾脏结构,血清尿酸、肌酐、尿素氮,大鼠尿α1微球蛋白、β2微球蛋白无明显影响,头孢替安钠500 mg·kg-1·d-1+呋塞米15 mg·kg-1·d-1给药后引起大鼠尿β2微球蛋白显著上升(P<0.05),血清尿酸显著下降(P<0.05)。结论:短期使用头孢替安钠对大鼠的肾功能及肾脏结构无明显影响,而头孢替安钠+呋塞米对大鼠尿β2微球蛋白及血清尿酸有一定影响。 Objective : To evaluate the safety of the combination of cefotiam sodium and furosemide and to provide the reference for clinical medication. Methods: Three groups were established, including the blank control group, cefotiam sodium group at the dosage of 500 mg- kg-1 1 d-1 , cefotiam sodium combined with furosemide group at the respective dosage of 500 mg 1 kg-1 - d-1 and 15 mg 1 kg-1 1 d-l. After the continuous administration for 12 days, the renal structure, serum uric acid, creatinine and urea nitrogen, u- rine of al microglobulin and β2 microglobulin in the rats were detected. Results: Cefotiam sodium at the dosage of 500 kg -1 . d- 1 showed no significant effects on the renal structure, serum uric acid, creatinine and urea nitrogen ,urine a1 microglobulin and β2 microglobulin in the rats. The combination- group showed significantly increased urine β2 microglobulin ( P 〈 0.05 ) and significantly decreased serum uric acid ( P ,〈 0.05 ). Conclusion : Short time use of cefotiam sodium exhibits no significant effect on the renal struc- ture and function in rats, while the combination of cefotiam sodium and furosemide has significant effects on urine β2 microglobulin and serum uric acid in rats.
出处 《中国药师》 CAS 2015年第1期161-163,共3页 China Pharmacist
关键词 头孢替安钠 呋塞米 合用 安全性 Cefotiam sodium Furosemide Combination use Safety
  • 相关文献

参考文献5

二级参考文献52

  • 1宫玉勇,张雪琳.青霉素与双黄连并用致过敏反应19例临床分析[J].药物流行病学杂志,2006,15(2):87-87. 被引量:3
  • 2马爱华,陆晓和.头孢曲松钠的不良反应分析[J].抗感染药学,2006,3(3):116-121. 被引量:11
  • 3Pannu N,Nadim MK.An overview of drug-induced acute kidney in-jury[J].Crit Care Med,2008,36(4 Suppl):S216-223. 被引量:1
  • 4Dean RT.Free radicals,membrane damage and cell-mediated cytoly-sis[J].Br J Cancer,1987,55:39-45. 被引量:1
  • 5Westhuyzen J,Endre ZH,Reece G,et al.Measurement of tubularenzymuria facilitates early detection of acute renal impairment intheintensive care unit[J].Nephrol Dial Transplant,2003,18(3):543-551. 被引量:1
  • 6Boucher HW, Corey GR. Epidemiology of methiciltin-resistant Staph- ylococcus aureus [J]. Clin Infect Dis, 2008,46 ( suppl 5 ) : $344-$349. 被引量:1
  • 7Bush K, Heep M, Macielag MJ, et al. Anti-MRSA -lactams in devel- opment, with a focus on ceftobiprole: the first anti-MRSA -lactam to demonstrate clinical efficacy[ J] . Expert Opin Investig Drugs, 2007, 16:419-429. 被引量:1
  • 8Davies TA, Page MG, Shang W, et al. Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumouiae[ J ]. Antimicrob Agents Chemotherm, 2007,51 : 2621- 2624. 被引量:1
  • 9Livermore DM. Can 13-1actams be re-engineered to beat MRSA [ J ]. Clin Microbiol Infect, 2006,12 ( suppl5 ) : 11-16. 被引量:1
  • 10Schmitt-Hoffmann A, Roos B, Schleimer M, et al. Single-dose phar- macokinetics and safety of a novel broad-spectrum cephalosporin (BAL5788) in healthy volunteers[J]. Antimicrob Agents Chemother, 2004,48 (7) :2570-2575. 被引量:1

共引文献29

同被引文献22

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部